The Lancet· Yasaman Vali, Kristy Wonders, Jenny Lee, Guruprasad P Aithal, Rocio Aller, Michael E D Allison, Johanna Arola, Jesus M Banales, Vanesa Bernal-Monterde, Annalisa Berzigotti, Jérôme Boursier, Clifford A Brass, Elisabetta Bugianesi, Jose Luis Calleja, Jeremy F Cobbold, Helena Cortez-Pinto, Javier Crespo, Susan Davies, Ann Driessen, Kevin L Duffin, Mattias Ekstedt, Daniel Forton, Céline Fournier-Poizat, Sven Francque, Andreas Geier, Joseph Gogain, Annette S H Gouw, Hannes Hagström, Adriaan G Holleboom, Prodromos Hytiroglou, Morten Karsdal, Carolin Lackner, Diana J Leeming, Luca Miele, George Papatheodoridis, Valerie Paradis, Michael Pavlides, Juan M Pericàs, Salvatore Petta, Vlad Ratziu, Manuel Romero-Gomez, Jörn M Schattenberg, Detlef Schuppan, Rambabu Surabattula, Ana Paula Silva, Mette Skalshøi Kjær, Beate K Straub, Gianluca Svegliati-Baroni, Dina Tiniakos, Maria Manuela Tonini, Richard Torstenson, Luca V C Valenti, Joanne Verheij, Jeremy Magnanensi, Rebeca Mayo, David Wenn, Hannele Yki-Järvinen, Carla Yunis, Patrick M Bossuyt, Quentin M Anstee, LITMUS Investigators·· 19 天前精选AI 评分58
LITMUS多中心研究:蛋白组学多标志物组合在MASLD无创检测中表现突出
[Articles] Non-invasive tests in metabolic dysfunction-associated steatotic liver disease: the LITMUS prospective multicentre diagnostic accuracy study
AI 导读
LITMUS前瞻性多中心诊断准确性研究显示,与组织学相比,单一标志物检测at-risk MASH的表现差异较大且有限,而多标志物组合展现出较大潜力,其中蛋白组学组合诊断性能较强。研究结果可为MASLD无创检测策略的选择与实施提供参考,并服务于未来临床指南、监管评估和临床试验设计。
推荐理由
LITMUS多中心诊断准确性研究比较了单一标志物与多标志物组合在检出at-risk MASH上的表现,为无创检测策略的选择提供依据。
来源:The Lancet · thelancet.com